171 related articles for article (PubMed ID: 30178714)
1. Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer.
Gałczyński K; Bełtowski J; Nowakowski Ł; Vasilevska D; Rechberger T; Semczuk A
Tumour Biol; 2018 Sep; 40(9):1010428318797869. PubMed ID: 30178714
[TBL] [Abstract][Full Text] [Related]
2. Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.
Rusek M; Pastryk JE; Bełtowski J
Chem Biol Interact; 2016 Nov; 259(Pt B):401-406. PubMed ID: 27387541
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
Perla-Kaján J; Jakubowski H
FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease.
Parada-Turska J; Wójcicka G; Beltowski J
Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967340
[TBL] [Abstract][Full Text] [Related]
5. The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.
Jakubowski H
Adv Exp Med Biol; 2010; 660():113-27. PubMed ID: 20221875
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase 1 and homocysteine metabolism.
Perła-Kaján J; Jakubowski H
Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
[TBL] [Abstract][Full Text] [Related]
7. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
Ferretti G; Bacchetti T; Marotti E; Curatola G
Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1.
Borowczyk K; Shih DM; Jakubowski H
J Alzheimers Dis; 2012; 30(2):225-31. PubMed ID: 22406444
[TBL] [Abstract][Full Text] [Related]
9. Modulation of paraoxonase 1 and protein N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat.
Beltowski J; Wójcicka G; Jakubowski H
J Endocrinol; 2010 Feb; 204(2):191-8. PubMed ID: 19887391
[TBL] [Abstract][Full Text] [Related]
10. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation.
Jakubowski H
J Biol Chem; 2000 Feb; 275(6):3957-62. PubMed ID: 10660550
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans.
Perła-Kaján J; Borowczyk K; Głowacki R; Nygård O; Jakubowski H
FASEB J; 2018 May; ():fj201800346R. PubMed ID: 29782204
[TBL] [Abstract][Full Text] [Related]
12. Processes of plasma protein N-homocysteinylation in multiple sclerosis.
Jamroz-Wiśniewska A; Bełtowski J; Bartosik-Psujek H; Wójcicka G; Rejdak K
Int J Neurosci; 2017 Aug; 127(8):709-715. PubMed ID: 27671515
[TBL] [Abstract][Full Text] [Related]
13. Effects of antiretroviral treatment on paraoxonase 1 (PON1) activity in rats.
Pastryk JE; Rusek M; Bełtowski J
Chem Biol Interact; 2016 Nov; 259(Pt B):407-412. PubMed ID: 27378623
[TBL] [Abstract][Full Text] [Related]
14. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
[TBL] [Abstract][Full Text] [Related]
15. Differential hydrolysis of homocysteine thiolactone by purified human serum (192)Q and (192)R PON1 isoenzymes.
Bayrak A; Bayrak T; Demirpençe E; Kılınç K
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):49-55. PubMed ID: 21123122
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
17. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
[TBL] [Abstract][Full Text] [Related]
18. Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients.
Jamroz-Wiśniewska A; Bełtowski J; Wójcicka G; Bartosik-Psujek H; Rejdak K
Oxid Med Cell Longev; 2020; 2020():1654754. PubMed ID: 32256946
[TBL] [Abstract][Full Text] [Related]
19. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
[TBL] [Abstract][Full Text] [Related]
20. [Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease].
Qin Q; Li YL; Zhao FM; Wang H; Li Y; Cui RZ; Zhao BR
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):803-7. PubMed ID: 17217688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
